Journal of Cancer Therapy
Vol.3 No.5(2012), Paper ID 23448, 9
pages
DOI:10.4236/jct.2012.35071
Rejection of Experimental Hodgkins Lymphoma by T-Cells Engineered with a CD19 Chimeric Antigen Receptor
Anna Swanson, Eleanor Cheadle, David Gilham, Dorothy Crawford, Simon Talbot, Ingo Johannessen
The University of Edinburgh, Centre for Infectious Diseases, Edinburgh, UK
The University of Manchester, Clinical and Experimental Immunology Group, Manchester, UK
The University of Manchester, Clinical and Experimental Immunology Group, Manchester, UK
The University of Edinburgh, Centre for Infectious Diseases, Edinburgh, UK
The University of Edinburgh, Division of Pathway Medicine, Chancellor’s Building, Edinburgh, UK
5Laboratory Medicine (Virology), Royal Infirmary of Edinburgh, Edinburgh, UK
Copyright © 2012 Anna Swanson, Eleanor Cheadle, David Gilham, Dorothy Crawford, Simon Talbot, Ingo Johannessen et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
A. Swanson, E. Cheadle, D. Gilham, D. Crawford, S. Talbot and I. Johannessen, "Rejection of Experimental Hodgkins Lymphoma by T-Cells Engineered with a CD19 Chimeric Antigen Receptor,"
Journal of Cancer Therapy, Vol. 3 No. 5, 2012, pp. 553-561. doi:
10.4236/jct.2012.35071.